These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 21447747)

  • 1. Regulation of whole body energy homeostasis with growth hormone replacement therapy and endurance exercise.
    Oosterhof R; Ith M; Trepp R; Christ E; Flück M
    Physiol Genomics; 2011 Jun; 43(12):739-48. PubMed ID: 21447747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth hormone regulation of metabolic gene expression in muscle: a microarray study in hypopituitary men.
    Sjögren K; Leung KC; Kaplan W; Gardiner-Garden M; Gibney J; Ho KK
    Am J Physiol Endocrinol Metab; 2007 Jul; 293(1):E364-71. PubMed ID: 17456639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of short-term therapy with recombinant human growth hormone (GH) on metabolic parameters and preclinical atherosclerotic markers in hypopituitary patients with growth hormone deficiency.
    Benedini S; Dalle Carbonare L; Albiger N; Scanarini M; Bilora F; Petrobelli F; Giannini S; Mantero F; Scaroni C
    Horm Metab Res; 2006 Jan; 38(1):16-21. PubMed ID: 16477535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional adaptations of lipid metabolism in tibialis anterior muscle of endurance-trained athletes.
    Schmitt B; Flück M; Décombaz J; Kreis R; Boesch C; Wittwer M; Graber F; Vogt M; Howald H; Hoppeler H
    Physiol Genomics; 2003 Oct; 15(2):148-57. PubMed ID: 14565968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of GH on human skeletal muscle lipid metabolism in GH deficiency.
    Trepp R; Flück M; Stettler C; Boesch C; Ith M; Kreis R; Hoppeler H; Howald H; Schmid JP; Diem P; Christ ER
    Am J Physiol Endocrinol Metab; 2008 Jun; 294(6):E1127-34. PubMed ID: 18413676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of growth hormone (GH) on fasting and postprandial metabolism in GH deficiency.
    Trepp R; Stettler C; Diem P; Christ ER
    Exp Clin Endocrinol Diabetes; 2010 Oct; 118(9):596-601. PubMed ID: 20146168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lower ability to oxidize lipids in adult patients with growth hormone (GH) deficiency: reversal under GH treatment.
    Brandou F; Aloulou I; Razimbaud A; Fédou C; Mercier J; Brun JF
    Clin Endocrinol (Oxf); 2006 Oct; 65(4):423-8. PubMed ID: 16984232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of resistance exercise and growth hormone administration at low doses on lipid metabolism in middle-aged female rats.
    Yang JY; Nam JH; Park H; Cha YS
    Eur J Pharmacol; 2006 Jun; 539(1-2):99-107. PubMed ID: 16687135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of growth hormone (GH) replacement therapy on sympathetic nerve hyperactivity in hypopituitary adults: a double-blind, placebo-controlled, crossover, short-term trial followed by long-term open GH replacement in hypopituitary adults.
    Sverrisdóttir YB; Elam M; Caidahl K; Söderling AS; Herlitz H; Johannsson G
    J Hypertens; 2003 Oct; 21(10):1905-14. PubMed ID: 14508197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of 24 months recombinant human growth hormone (rh-GH) on LDL cholesterol, triglyceride-rich lipoproteins and apo [a] in hypopituitary adults previously treated with conventional replacement therapy.
    O'Neal DN; Hew FL; Best JD; Alford F
    Growth Horm IGF Res; 1999 Jun; 9(3):165-73. PubMed ID: 10502452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone and testosterone interact positively to enhance protein and energy metabolism in hypopituitary men.
    Gibney J; Wolthers T; Johannsson G; Umpleby AM; Ho KK
    Am J Physiol Endocrinol Metab; 2005 Aug; 289(2):E266-71. PubMed ID: 15727949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aspects of growth hormone deficiency and replacement in elderly hypopituitary adults.
    Feldt-Rasmussen U; Wilton P; Jonsson P; ;
    Growth Horm IGF Res; 2004 Jun; 14 Suppl A():S51-8. PubMed ID: 15135778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of 5 years of growth hormone replacement therapy on cardiovascular risk factors in growth hormone-deficient adults.
    Cenci MC; Conceição FL; Soares DV; Spina LD; Brasil RR; Lobo PM; Michmacher E; Vaisman M
    Metabolism; 2008 Jan; 57(1):121-9. PubMed ID: 18078869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baseline characteristics and the effects of two years of growth hormone replacement therapy in adults with growth hormone deficiency previously treated for Cushing's disease.
    Johannsson G; Sunnerhagen KS; Svensson J
    Clin Endocrinol (Oxf); 2004 May; 60(5):550-9. PubMed ID: 15104557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of in vivo growth hormone treatment on blood gene expression in adults with growth hormone deficiency reveals potential biomarkers to monitor growth hormone therapy.
    Fernández-Pérez L; Nóvoa J; Ståhlberg N; Santana-Farré R; Boronat M; Marrero D; Henríquez-Hernández L; Norstedt G; Flores-Morales A
    Clin Endocrinol (Oxf); 2010 Jun; 72(6):800-6. PubMed ID: 19849699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolated growth hormone (GH) deficiency in adult patients: baseline clinical characteristics and responses to GH replacement in comparison with hypopituitary patients. A sub-analysis of the KIMS database.
    Abs R; Mattsson AF; Bengtsson BA; Feldt-Rasmussen U; Góth MI; Koltowska-Häggström M; Monson JP; Verhelst J; Wilton P;
    Growth Horm IGF Res; 2005 Oct; 15(5):349-59. PubMed ID: 16168692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The consequences of growth hormone deficiency in adulthood, and the effects of growth hormone replacement.
    Christ ER; Carroll PV; Russell-Jones DL; Sönksen PH
    Schweiz Med Wochenschr; 1997 Aug; 127(35):1440-9. PubMed ID: 9297747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein metabolism in Turner syndrome and the impact of hormone replacement therapy.
    Gravholt CH; Riis AL; Møller N; Christiansen JS
    Clin Endocrinol (Oxf); 2007 Sep; 67(3):413-8. PubMed ID: 17561982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skeletal muscle fat and carbohydrate metabolism during recovery from glycogen-depleting exercise in humans.
    Kimber NE; Heigenhauser GJ; Spriet LL; Dyck DJ
    J Physiol; 2003 May; 548(Pt 3):919-27. PubMed ID: 12651914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole body metabolic effects of prolonged endurance training in combination with erythropoietin treatment in humans: a randomized placebo controlled trial.
    Christensen B; Nellemann B; Larsen MS; Thams L; Sieljacks P; Vestergaard PF; Bibby BM; Vissing K; Stødkilde-Jørgensen H; Pedersen SB; Møller N; Nielsen S; Jessen N; Jørgensen JO
    Am J Physiol Endocrinol Metab; 2013 Oct; 305(7):E879-89. PubMed ID: 23921143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.